Jump to content

Chuen Yan Cheng

From Wikipedia, the free encyclopedia
Prof Chuen Yan Cheng
Born (1954-06-18) June 18, 1954 (age 70)
NationalityAmerican
Alma materChinese University of Hong Kong (B.Sc.)
University of Newcastle, Australia (Ph.D.)
Known forMale contraceptive drug
AwardsRichard E. Weizman Memorial Award
Best Scientific Paper Award
Scientific career
FieldsBiochemistry
InstitutionsRockefeller University

Chuen Yan Cheng (Chinese: 鄭泉恩) is a Senior Scientist for the Population Council's Center for Biomedical Research. He is most well known as the inventor of the non-steroid male contraceptive drug——Adjudin,[1][2][3][4] which is the first male contraceptive drug on the market now finished clinical trials showing no side effects.[5][6]

Career

[edit]

He graduated from the Chinese University of Hong Kong with a B.Sc. in 1977, and obtained his Ph.D. in biochemistry and cell biology at the University of Newcastle, Australia, in 1981. He came to New York as a Population Council post-doctoral trainee in 1981, studying in the laboratory of Drs. Wayne Bardin, Neal Musto, and Glen Gunsalus and was appointed as a research investigator in December 1982.

Cheng's research focuses on the development of a novel contraceptive for human males. These studies currently are supported by grants from the National Institutes of Health, the CONRAD Program, and the Andrew Mellon Foundation.

References

[edit]
  1. ^ "Obsessed Scientist Finally Throttles 'Em! Non-Paternity Potion". The New York Observer. Archived from the original on 2008-09-24. Retrieved 2008-09-28.
  2. ^ "Future male "pill" targets testicles". Retrieved 2008-09-28.
  3. ^ "Male pill - Science Base". Retrieved 2008-09-28.
  4. ^ "Seed: The Hunt for Male Birth Control". Archived from the original on 2006-11-03. Retrieved 2008-09-28.{{cite web}}: CS1 maint: unfit URL (link)
  5. ^ "Trials for alternative male Pill show no side-effects". Retrieved 2008-09-28.
  6. ^ "Male Contraceptive Drug in the Works". Retrieved 2008-09-28.
[edit]